Yu-chen Pei

Key Laboratory Of Breast Cancer
Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.

Genetic interactions reveal distinct biological and therapeutic implications in breast cancer.

Journal: Cancer cell

Published: July 26, 2023

Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities.

Comprehensive genomic profiling of breast cancers characterizes germline-somatic mutation interactions mediating therapeutic vulnerabilities.

Journal: Cell discovery

Published: July 13, 2023

In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer.

In vivo multidimensional CRISPR screens identify Lgals2 as an immunotherapy target in triple-negative breast cancer.

Journal: Science advances

Published: June 29, 2022

An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression.

An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression.

Journal: Cancer research

Published: February 14, 2022

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing.

Characterization of the genomic landscape and actionable mutations in Chinese breast cancers by clinical sequencing.

Journal: Nature communications

Published: April 18, 2020

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets.

Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets.

Journal: Cell metabolism

Published: April 05, 2020

Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer.

Molecular Features and Functional Implications of Germline Variants in Triple-Negative Breast Cancer.

Journal: Journal of the National Cancer Institute

Published: March 16, 2020

Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer.

Truncated HDAC9 identified by integrated genome-wide screen as the key modulator for paclitaxel resistance in triple-negative breast cancer.

Journal: Theranostics

Published: February 17, 2020

CircRNAFisher: a systematic computational approach for de novo circular RNA identification.

CircRNAFisher: a systematic computational approach for de novo circular RNA identification.

Journal: Acta pharmacologica Sinica

Published: December 18, 2017

Showing 1-9 of 9

Last Updated: 09/26/2026